BALANCE SHEET
GlaxoSmithKline Pharmaceuticals Ltd.
BSE
Jun 06
3431.50
-28.20 ( -0.82%)
Volume
5384
Prev. Close
3459.70
Open Price
3458.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 06
3438.50
-27.70 ( -0.80%)
Volume
149126
Prev. Close
3466.20
Open Price
3451.10
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Balance Sheet
for the last 5 years.
|
ISIN No
|
INE159A01016
|
Market Cap. ( ₹ in Cr. )
|
58250.26
|
P/BV
|
34.82
|
Book Value ( ₹ )
|
98.74
|
|
BSE Code
|
500660
|
52 Week High/Low ( ₹ )
|
3516/1921
|
FV/ML
|
10/1
|
P/E(X)
|
62.80
|
|
NSE Code
|
GLAXOEQ
|
Book Closure
|
30/05/2025
|
EPS ( ₹ )
|
54.75
|
Div Yield (%)
|
1.57
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| No. of Equity Shares (in Lacs) | 1694.10 | 1694.06 | 1694.06 | 1694.06 | 1694.06 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| Total Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| | | | | | |
| Reserves and Surplus | 1781.90 | 1617.24 | 1573.54 | 2493.55 | 1308.85 |
| Total Reserves and Surplus | 1781.90 | 1617.24 | 1573.54 | 2493.55 | 1308.85 |
| Employees Stock Options | 0.00 | -9.01 | -1.68 | 0.00 | 0.00 |
| Total Shareholders Funds | 1951.31 | 1777.64 | 1741.27 | 2662.96 | 1478.26 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Other Long Term Liabilities | 2.49 | 6.57 | 4.14 | 9.68 | 22.31 |
| Long Term Provisions | 249.11 | 247.46 | 254.80 | 262.21 | 259.50 |
| Total Non-Current Liabilities | 251.60 | 254.03 | 258.94 | 271.89 | 281.81 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Trade Payables | 708.26 | 625.41 | 427.79 | 570.55 | 466.13 |
| Other Current Liabilities | 780.50 | 506.02 | 480.79 | 799.90 | 613.80 |
| Short Term Provisions | 416.41 | 393.52 | 417.79 | 327.98 | 274.62 |
| Total Current Liabilities | 1905.17 | 1524.95 | 1326.37 | 1698.43 | 1354.58 |
| | | | | | |
| Total Capital And Liabilities | 4108.08 | 3556.62 | 3326.58 | 4633.28 | 3114.65 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 270.32 | 297.72 | 295.87 | 296.15 | 343.55 |
| Intangible Assets | 13.33 | 23.55 | 34.09 | 34.50 | 43.36 |
| Capital Work-In-Progress | 14.32 | 13.93 | 20.31 | 30.50 | 13.21 |
| Fixed Assets | 297.97 | 335.20 | 350.27 | 361.15 | 400.12 |
| Deferred Tax Assets [Net] | 140.87 | 146.31 | 133.55 | 113.15 | 103.13 |
| Long Term Loans And Advances | 0.00 | 0.00 | 70.00 | 190.00 | 0.00 |
| Other Non-Current Assets | 259.35 | 276.68 | 278.50 | 260.95 | 408.76 |
| Total Non-Current Assets | 698.19 | 758.20 | 832.32 | 925.25 | 912.01 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 1118.25 | 813.22 | 518.29 | 365.59 | 0.00 |
| Inventories | 481.74 | 525.05 | 459.97 | 534.70 | 546.70 |
| Trade Receivables | 292.55 | 222.06 | 192.38 | 205.24 | 215.60 |
| Cash And Cash Equivalents | 1403.52 | 1063.22 | 1155.93 | 2484.51 | 1157.96 |
| OtherCurrentAssets | 113.83 | 174.87 | 167.70 | 118.00 | 282.37 |
| Total Current Assets | 3409.89 | 2798.42 | 2494.26 | 3708.03 | 2202.64 |
| | | | | | |
| Total Assets | 4108.08 | 3556.62 | 3326.58 | 4633.28 | 3114.65 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 0.00 | 387.14 | 361.80 | 368.97 | 498.50 |
| | | | | | |
| BONUS DETAILS | | | | | |
| Bonus Equity Share Capital | 0.00 | 125.39 | 125.39 | 125.39 | 125.39 |